1182357-16-9 Usage
Description
1-Bromo-2-(chloromethyl)-3-fluorobenzene is an organic compound characterized by its chemical formula C7H5BrClF. It is a colorless liquid with a molecular weight of 207.47 g/mol. This versatile chemical intermediate is widely utilized in the synthesis of pharmaceuticals, agrochemicals, and specialty chemicals, as well as serving as a building block in organic synthesis.
Uses
Used in Pharmaceutical Industry:
1-Bromo-2-(chloromethyl)-3-fluorobenzene is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, 1-Bromo-2-(chloromethyl)-3-fluorobenzene is employed as a precursor in the production of agrochemicals, contributing to the development of effective pest control agents and other agricultural products.
Used in Specialty Chemicals:
1-Bromo-2-(chloromethyl)-3-fluorobenzene is utilized in the preparation of specialty chemicals, which are high-value products used in various applications, such as coatings, adhesives, and sealants.
Used in Organic Synthesis:
As a building block in organic synthesis, 1-Bromo-2-(chloromethyl)-3-fluorobenzene is used to construct more complex organic molecules, enabling the creation of innovative compounds with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1182357-16-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,2,3,5 and 7 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1182357-16:
(9*1)+(8*1)+(7*8)+(6*2)+(5*3)+(4*5)+(3*7)+(2*1)+(1*6)=149
149 % 10 = 9
So 1182357-16-9 is a valid CAS Registry Number.
1182357-16-9Relevant articles and documents
COMPOUNDS
-
Page/Page column 57, (2018/12/03)
Provided are benzoxazolinone sulfonamide derivatives that inhibit Na v1.7 activity, pharmaceutical compositions containing them and their use in therapy for the treatment of diseases mediated by Na v1.7 activity.
